
Sign up to save your podcasts
Or


Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.
By Dr. Neil Love4.4
7272 ratings
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.

321 Listeners

39 Listeners

65 Listeners

30 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

59 Listeners

1,150 Listeners

46 Listeners

2 Listeners

367 Listeners

53 Listeners

59 Listeners

51 Listeners

195 Listeners

45 Listeners

30 Listeners

0 Listeners